Treating Obesity as a Risk Reduction Strategy for Cancer
August 13, 2024 — For the second time in the past few months, a signal from the surveillance of GLP-1 agonists is surfacing to suggest that these drugs may offer a risk reduction strategy for cancer. Earlier, the signal came from a study of persons receiving treatment for diabetes. The present study, presented at the recent annual meeting for […]
